Axcelis dominates the Ion Implanter industry and is entering a positive revision cycle. The company positively pre-announced at the July 9th Investor Day and provided 2027 EPS targets 10% ahead of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results